Clik here to view.
Endotronix Announces Development Agreement for a New Expanded U.S....
Company is constructing a new commercial manufacturing facility and anticipates expanding its workforce to support the launch of its comprehensive patient management platform for heart failure LISLE,...
View ArticleMedical technology company moving headquarters to 80,000 square-foot...
The post Medical technology company moving headquarters to 80,000 square-foot Naperville facility appeared first on Endotronix.
View ArticleEndotronix expands headquarters in Illinois
The post Endotronix expands headquarters in Illinois appeared first on Endotronix.
View ArticleClik here to view.
Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure...
Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE, IL –...
View ArticleClik here to view.
Endotronix Announces Enrollment Completion of PROACTIVE-HF Pivotal Trial
Data to support regulatory submission and accelerate U.S. market access for the CordellaTM Pulmonary Artery (PA) Sensor CordellaTM is the first and only patient management platform to provide both...
View ArticlePresented at HFSA 2021: Remote Patient Management Facilitates Guideline...
The post Presented at HFSA 2021:<br> Remote Patient Management Facilitates Guideline Directed Medical Therapy Improving Outcomes appeared first on Endotronix.
View ArticleClik here to view.
Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design...
Amended study design provides immediate access and clinical benefits for all patients and becomes the first global IDE study for PA pressure-guided heart failure management LISLE, IL – JANUARY 5, 2022...
View ArticleClik here to view.
Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical...
Study met all primary safety and efficacy endpoints for the Cordella PA Pressure Sensor System for the treatment of NYHA class III heart failure patients LISLE, IL – MAY 23, 2022 – Endotronix, Inc., a...
View ArticleEndotronix reports promising study results for sensor used to manage heart...
The post Endotronix reports promising study results for sensor used to manage heart failure appeared first on Endotronix.
View ArticleCordella meets safety and efficacy endpoints in SIRONA 2 clinical Trial
The post Cordella meets safety and efficacy endpoints in SIRONA 2 clinical Trial appeared first on Endotronix.
View ArticleClik here to view.
Endotronix Announces Development Agreement for a New Expanded U.S....
Company is constructing a new commercial manufacturing facility and anticipates expanding its workforce to support the launch of its comprehensive patient management platform for heart failure LISLE,...
View ArticleMedical technology company moving headquarters to 80,000 square-foot...
The post Medical technology company moving headquarters to 80,000 square-foot Naperville facility appeared first on Endotronix.
View ArticleEndotronix expands headquarters in Illinois
The post Endotronix expands headquarters in Illinois appeared first on Endotronix.
View ArticleClik here to view.
Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure...
Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE, IL –...
View ArticleClik here to view.
Endotronix Announces Enrollment Completion of PROACTIVE-HF Pivotal Trial
Data to support regulatory submission and accelerate U.S. market access for the CordellaTM Pulmonary Artery (PA) Sensor CordellaTM is the first and only patient management platform to provide both...
View ArticleEndotronix Extends Positive Outcomes with 12-month Data Release from the...
The study met secondary study endpoints and long-term sensor use was associated with significant improvements in patient quality-of-life metrics and low event rates for heart failure hospitalization...
View ArticleMedical technology company moving headquarters to 80,000 square-foot...
The post Medical technology company moving headquarters to 80,000 square-foot Naperville facility appeared first on Endotronix.
View ArticleEndotronix expands headquarters in Illinois
The post Endotronix expands headquarters in Illinois appeared first on Endotronix.
View ArticleClik here to view.
Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure...
Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE, IL –...
View ArticleClik here to view.
Endotronix Announces Enrollment Completion of PROACTIVE-HF Pivotal Trial
Data to support regulatory submission and accelerate U.S. market access for the CordellaTM Pulmonary Artery (PA) Sensor CordellaTM is the first and only patient management platform to provide both...
View Article